The primary goal of the study was to determine the safety and tolerability of the new therapy.
研究的基本目标是确定新疗法的安全性和耐受性。
Safety and tolerability profiles of the combination regimen were as expected, with no new or unexpected toxicities observed.
联合治疗的安全性和耐受性数据也如预期相同,在实验中没有观察到新的或者意外的毒性现象。
The primary objective of these Phase 1/2 studies is to assess the safety and tolerability of these stem cell-derived transplants.
这些阶段的主要目的是评估1/2研究的安全性和耐受性这些干细胞源性移植。
应用推荐